November 7, 2022
Mihoko Kobayashi, Director, Japan Development Leader, Rare Disease, Clinical Research, Pfizer R&D Japan Pharma companies and industry organizations are expressing concern that the development of gene therapies in Japan is being stymied by the Cartagena Act, a law regarding the...read more